# Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C

> **NCT00540345** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 300 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** pegylated interferon alpha 2a and plus ribavirin
- **DRUG:** Pegylated interferon alfa-2a and ribavirin
- **DRUG:** pegylated interferon alpha 2a and ribavirin
- **DRUG:** pegylated interferon alpha 2a and ribavirin

## Key facts

- **NCT ID:** NCT00540345
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540345, "Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00540345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
